TARGETING SERINE AND 1-CARBON METABOLISM FOR THE TREATMENT OF RB-DEFICIENT AGGRESSIVE-VARIANT PROSTATE CANCER
$1,327,793FY2025Defense Health AgencyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center